Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Tauschmann

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Hormone Research in Paediatrics|January 30, 2025
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose MonitoringMartin Tauschmann, Roque Cardona-Hernandez, Daniel J DeSalvo, et al.
The Lancet. Diabetes & Endocrinology|December 19, 2024
Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2-20 years) with type 1 diabetes: a population-based studyBeate Karges, Joachim Rosenbauer, Anna Stahl-Pehe, et al.
Pediatric Diabetes|April 30, 2025
Basal and Bolus Insulin Distribution According to Treatment Modality: Data from SWEET Diabetes RegistryFerda Evin, Sascha R Tittel, Barbara Piccini, et al.
European Journal of Nutrition|July 2, 2015
Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tractMina Bashir, Barbara Prietl, Martin Tauschmann, et al.
Diabetes Care|January 8, 2016
Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical TrialMartin Tauschmann, Janet M Allen, Malgorzata E Wilinska, et al.
Diabetes, Obesity & Metabolism|June 16, 2026
Long-Term Associations Between Energy Expenditure and CGM-Derived Metrics in Adults With Type 1 Diabetes: A Retrospective Analysis of the Syntactiq Cockpit DatabaseKatharina Bünzel, Sabrina Sanfilippo, Janis Schierbauer, et al.
Diabetes Technology & Therapeutics|February 6, 2019
Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative StudyJulia Lawton, Maxine Blackburn, David Rankin, et al.
Pediatric Diabetes|January 27, 2022
Three-variate trajectories of metabolic control, body mass index, and insulin dose: Heterogeneous response to initiation of pump therapy in youth with type 1 diabetesMartin Tauschmann, Anke Schwandt, Nicole Prinz, et al.
JAMA Network Open|February 22, 2023
Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 DiabetesKlemen Dovc, Stefanie Lanzinger, Roque Cardona-Hernandez, et al.
Journal of the Endocrine Society|April 10, 2026
A worldwide perspective on clinical characteristics and treatment of youth with monogenic diabetes in the SWEET registryLily Deng, Stefanie Lanzinger, Kristina Casteels, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Hormone Research in Paediatrics|January 30, 2025
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose MonitoringMartin Tauschmann, Roque Cardona-Hernandez, Daniel J DeSalvo, et al.
The Lancet. Diabetes & Endocrinology|December 19, 2024
Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2-20 years) with type 1 diabetes: a population-based studyBeate Karges, Joachim Rosenbauer, Anna Stahl-Pehe, et al.
Pediatric Diabetes|April 30, 2025
Basal and Bolus Insulin Distribution According to Treatment Modality: Data from SWEET Diabetes RegistryFerda Evin, Sascha R Tittel, Barbara Piccini, et al.
European Journal of Nutrition|July 2, 2015
Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tractMina Bashir, Barbara Prietl, Martin Tauschmann, et al.
Diabetes Care|January 8, 2016
Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical TrialMartin Tauschmann, Janet M Allen, Malgorzata E Wilinska, et al.
Diabetes, Obesity & Metabolism|June 16, 2026
Long-Term Associations Between Energy Expenditure and CGM-Derived Metrics in Adults With Type 1 Diabetes: A Retrospective Analysis of the Syntactiq Cockpit DatabaseKatharina Bünzel, Sabrina Sanfilippo, Janis Schierbauer, et al.
Diabetes Technology & Therapeutics|February 6, 2019
Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative StudyJulia Lawton, Maxine Blackburn, David Rankin, et al.
Pediatric Diabetes|January 27, 2022
Three-variate trajectories of metabolic control, body mass index, and insulin dose: Heterogeneous response to initiation of pump therapy in youth with type 1 diabetesMartin Tauschmann, Anke Schwandt, Nicole Prinz, et al.
JAMA Network Open|February 22, 2023
Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 DiabetesKlemen Dovc, Stefanie Lanzinger, Roque Cardona-Hernandez, et al.
Journal of the Endocrine Society|April 10, 2026
A worldwide perspective on clinical characteristics and treatment of youth with monogenic diabetes in the SWEET registryLily Deng, Stefanie Lanzinger, Kristina Casteels, et al.
Pageof 7